Adam J Gordon

An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program

Julie M Donohue, Wei-Hsuan Lo-Ciganic, W. Gellad, 2017, Medical care.

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Rosalie Liccardo Pacula, Sebastian Bauhoff, R. Pacula, 2015, The Milbank quarterly.

Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients

Declan T. Barry, S. Crystal, A. Justice, 2015, Journal of acquired immune deficiency syndromes.

Defining Nonmedical Use of Prescription Opioids within Health Care Claims: A Systematic Review

Julie M Donohue, Wei-Hsuan Lo-Ciganic, W. Gellad, 2015, Substance abuse.

Policies Related to Opioid Agonist Therapy for Opioid Use Disorders: The Evolution of State Policies from 2004 to 2013

Sebastian Bauhoff, R. Pacula, Rachel M. Burns, 2016, Substance abuse.

An experimental study of the agreement of self-administration and telephone administration of the Timeline Followback interview.

A. Justice, S. Maisto, A. Gordon, 2008, Journal of studies on alcohol and drugs.

Supply of buprenorphine waivered physicians: the influence of state policies.

Rosalie Liccardo Pacula, Carrie M. Farmer, R. Pacula, 2015, Journal of substance abuse treatment.

Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program

Julie M Donohue, Wei-Hsuan Lo-Ciganic, D. Kelley, 2015, Journal of addiction medicine.

The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.

Carrie M. Farmer, J. Schuster, A. Gordon, 2012, Drug and alcohol dependence.